These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2001555)

  • 21. Distribution of 486P 3/12 antigen, ABO(H) blood group antigen and T antigen in cystectomy specimens from patients with stage T2 transitional cell carcinoma of the bladder.
    Heinzer H; Huland E; Mönk M; Huland H
    J Urol; 1992 Sep; 148(3):802-5. PubMed ID: 1512830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72.
    Clemo FA; DeNicola DB; Carlton WW; Walker E; Morrison WB
    Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneic expression of blood group A and H isoantigens in bladder tumors: association with nuclear volume.
    Orntoft TF; Nielsen K
    J Histochem Cytochem; 1989 Jul; 37(7):1153-5. PubMed ID: 2732458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
    Das G
    Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
    Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
    Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
    Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
    Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder.
    Malmström PU; Norlén BJ; Andersson B; Busch C
    Br J Urol; 1989 Jul; 64(1):49-55. PubMed ID: 2765768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.
    Jakse G; Hofstädter F
    Urol Res; 1981; 9(3):153-6. PubMed ID: 7257030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of A, B or O (H) surface antigen specificity: carcinoma in situ and non-malignant lesions of the bladder.
    Emmott RC; Droller MJ; Javadpour N
    J Urol; 1981 Jan; 125(1):32-5. PubMed ID: 6162036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABH cell surface isoantigens in invasive bladder carcinoma associated with schistosomiasis.
    El Adl MM; Yamase HT; Nieh PT; Mostofa AS; Hinz CF; Walzak MP
    J Urol; 1984 Feb; 131(2):249-51. PubMed ID: 6366249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ABH isoantigen of superficial urothelial tumor and carcinoma in situ of the bladder by the avidin-biotin peroxidase complex(ABC) method].
    Sasaki K
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1326-38. PubMed ID: 6374223
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Coon JS; Weinstein RS; Summers JL
    Am J Clin Pathol; 1982 Jun; 77(6):692-9. PubMed ID: 7091049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma.
    Newman AJ; Carlton CE; Johnson S
    J Urol; 1980 Jul; 124(1):27-9. PubMed ID: 7411715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies.
    Chopin DK; deKernion JB
    Urol Res; 1986; 14(3):145-8. PubMed ID: 3529570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder.
    Young AK; Hammond E; Middleton AW
    J Urol; 1979 Oct; 122(4):462-4. PubMed ID: 480485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.